Life Sciences

The Joint Army Contracting Command and the Joint COVID Response Division (ACC-JCRD) recently published a solicitation seeking Commercial Solutions to decrease US reliance on fragile global supply chains and increase preparedness for future pandemics. The solicitation seeks to establish, expand, and accelerate the availability of domestically-produced supplies in several different areas, some of which may […]

Executive Summary BARDA’s suspension of funding for COVID-19 therapeutics risks repeating mistakes of past pandemics as it may cause industry to pull out of the development space, experts say. Industry sources are concerned the Biden administration is focusing on funding NIH at the expense of BARDA. The Biomedical Advanced Research and Development Authority quietly suspended

The DPA Title III program just received an additional $10B in the recovery legislation that was recently passed. The DPA program is administered by the US Air Force and more information can be found here beta.SAM.gov. The solicitation is open until JUL 2024 to offerors that meet the requirements of the Defense Production Act of

Recently we became aware of two new opportunities for federal funding through HHS and DoD. We believe these may present exciting new avenues for companies that work in these areas. First, BARDA just posted two new RFIs with a response deadline of April 23, 2021. Links to these are here: beta.SAM.gov | Search – Expansion

Recently, the Coalition for Epidemic Preparedness Innovations (CEPI) published a call for proposals that is open from 28 JAN 2021 to 28 MAY 2021 and can be found here [CEPICfPCallText.pdf]. Trials that expand access in low and middle income countries is strongly encouraged. The objective is to expand access to vaccines that are already in

Recently BARDA published information about the COVID programs the USG is supporting through collaboration between HHS and DoD. Some of that information is summarized in the  table below. In the rush to respond to the COVID pandemic the portfolio became unbalanced, especially regarding therapeutics. With the new administration there is interest and funding available to

The Biomedical Advanced Research and Development Authority (BARDA) recently published a Presolicitation Notice for a project titled ‘BARDA Chemical Animal Model Development” [beta.SAM.gov | Search]. The Notice announces BARDA’s intention to publish an RFP for the same project on or around February 14, 2021. The RFP seeks proposals related to testing services, not product development.

Although it may seem that COVID gets all the attention, there are still funding opportunities in other infectious disease areas. For example, the US Agency for International Development (USAID) just published an addendum to their BAA [beta.SAM.gov] regarding a program called The Microbicide 2020 R&D Project: Advancing the Research and Development of Innovative HIV Prevention

During his first week in office President Biden followed through on his promise for swift executive action to address COVID. One Executive Order (EO) focused on COVID care and treatments (Improving and Expanding Access to Care and Treatments for COVID-19). One section of this EO aims to accelerate the development of novel therapies. It call

The US Army Medical Research and Development Command (USAMRDC) has published a Request for Information (RFI) related to the Joint Warfighter Medical Research Program (JWMRP). This program provides additional funding for projects that were previously funded through a DoD office. The full SSN can be found here : (https://sam.gov/content/home). JWMRP considers projects in five areas

In case you missed it during the holidays, a Request for Information (RFI) was published that may be of interest to you. A link to the RFI is here: (https://sam.gov/content/home). Publication of such a RFI is an indication that a solicitation for white papers and proposals will soon follow. Based on this, it looks like

Putting the best foot forward in the white paper is very important and EverGlade can help you take that step successfully. Our staff has over 40 years of cumulative experience on both sides of the table- preparation of white papers and their review. We have the same experience with the preparation of full proposals and